The FDA-approved Guardian system is a patient warning system used for acute coronary syndrome events, including silent heart attacks, according to a July 27 press release.
The device was implanted during an outpatient procedure performed by Andrew Kaplan, MD, at Cardiovascular Associates of Mesa in Arizona. Dr. Kaplan was a clinical trial investigator for the system and serves on the company’s medical advisory board.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
